Installed for fifty years between Chilly-Mazarin and Longjumeau, a few hundred meters from the A6 motorway, the Sanofi site is part of the landscape.
However, in a little over a year, it will be over.
The management of the group of the French pharmaceutical giant formalized at the end of the week the definitive closure of its research and development (R&D) center located in Essonne, specializing in the discovery and development of innovative therapies, in the field of oncology in particular.
Subscribe to read more
Already subscribed?
To log in